Golo Ahlenstiel
Professor
MBBS/MD/PhD/FRACP
g.ahlenstiel@westernsydney.edu.au
Currently open to PHD and Honours students in the topic areas of:
Immunology
Innate immunity
Liver disease
Viral hepatitis
Cancer immunology

Biography
Professor Golo Ahlenstiel is Chair of Medicine at Blacktown Clinical School, Western Sydney University, and Clinical Network Director for Specialty Medicine in Western Sydney Local Health District.
After completing his medical degree and MD/PhD at the University of Bonn in Germany, Golo Ahlenstiel received research fellowships from the National Institutes of Health (NIH, USA) and the German Research Foundation to pursue liver immunology research at the National Institutes of Health, Bethesda, MD, USA in 2004. In 2009 Golo Ahlenstiel moved to Sydney where he completed basic physician and advanced training in Gastroenterology/Hepatology in WSLHD in 2013. In 2014 he was appointed Associate Professor at the University of Sydney and full time staff specialist in Gastroenterology/Hepatology at Westmead Hospital. In 2017, he moved to Blacktown-Mount Druitt Hospital as Chair of Medicine.
He is an academic hepatologist with over 7000 career citations. He is Faculty at the Westmead Institute for Medical Research, and member of the Liver Faculty Executive of GESA, and the TRIPLE III Executive of SPHERE / Maridulu Budyari Gumal. He leads active translational research programs in liver immunology at the Westmead Institute, as well as metabolic disease., liver cirrhosis and immunotherapy of cancer at Blacktown Clinical School.
Research interests
Liver Immunology, Liver cirrhosis and portal hypertension, Innate immunity, Cancer immunology, Chronic liver disease
Adjunct roles
Chair of Medicine. Blacktown Clinical School | Western Sydney University |
Network Director Specialty Medicine | Western Sydney LHD |
Head of Department, Gastroenterology & Hepatology | Blacktown Hospital |
Additional information
ORCID: https://orcid.org/0000-0003-0026-1457
Google scholar: https://scholar.google.com.au/citations?user=wUUjgUEAAAAJ&hl=en
Research Gate: https://www.researchgate.net/profile/Golo-Ahlenstiel
Current grants
Bristol Myers Squibb Investigator Sponsored Research Grant | 2021-2024 | Risk factors of liver and gastrointestinal adverse events in cancer patients treated with Ipilimumab + Nivolumab (CA209-6KR). |
MRFF - Optimising the Clinical Use of Immunoglobulins | 2022-2027 | antiCD20 treatment to rationalise the use of IV/SC-IG in CIDP |
MRFF- COVID-19 Health Impacts and Vaccination Schedules | 2022-2027 | Comparing Immunisation-boosting Regimens for COVID-19 Upon Initiation of immunosuppressive Therapies (CIRCUIT Study) |
Affiliations
GESA, Liver Faculty, WSLHD, TRIPLE III Executive of SPHERE / Maridulu Budyari Guma
Professional Associations and Organisations
2021/22 | WSLHD/ICCH | Senior Medical Advisor COVID-inTouch |
2014-22 | USYD/Westmead Clinical School | Associate Professor (conjoin/hon) |
2020-21 | WSLHD/BMDH | Acting Director Division 3 |
2014-17 | WSLHD/Westmead | Staff Specialist Gastroenterology |
Awards and recognition
Fellow GESA (FGESA) 2022 |
WSLHD Award for Collaborative Leadership 2022 |
NSW Public Servant of the Year, Finalist 2022 |
Westmead Institute Scientific Excellence (WISE Award) 2018 |